Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors

SIMPLE SUMMARY: The tumor suppressor TAp73 is a member of the p53 family, which is inhibited in many human solid and hematological tumors. In contrast to those in the p53 gene, mutations in the p73 gene are very rare in tumors, suggesting that the decrease in TAp73 activity and expression detected i...

Descripción completa

Detalles Bibliográficos
Autores principales: Omran, Ziad, H. Dalhat, Mahmood, Abdullah, Omeima, Kaleem, Mohammed, Hosawi, Salman, A Al-Abbasi, Fahd, Wu, Wei, Choudhry, Hani, Alhosin, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071514/
https://www.ncbi.nlm.nih.gov/pubmed/33921128
http://dx.doi.org/10.3390/cancers13081916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071514/
https://www.ncbi.nlm.nih.gov/pubmed/33921128
http://dx.doi.org/10.3390/cancers13081916

Ejemplares similares